This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
You do not have access to the full text of this article, the first page of the PDF of this article appears above.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
January 2021
Volume 9, Issue 1
Volume 9, Issue 1
A Sampling of Highlights from the Literature
Jump to section
- Article
- Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans
- Innate immune training of granulopoiesis promotes anti-tumor activity
- Improving CAR T-cell therapy for solid tumors
- Defining HPV-specific B cell responses in patients with head and neck cancer
- CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response
- Antagonistic inflammatory phenotypes dictate tumor fate and response to immune checkpoint blockade
- Info & Metrics
Advertisement